ABSTRACT
Increased indicators of fat metabolites are found in Equine Metabolic Syndrome (EMS) subjects, although these parameters are not included in the EMS definition described in the literature and in its diagnosis. The objective of this study was to characterize dyslipidemia in obese insulin resistant mares. 18 mares were allocated in three groups according to body condition score (BCS) in a 1 to 9 scale. In the Ideal group there were animals with BCS 4.5 to 5.5 (n= 6), in the Overweight group, the BCS were 6 to 7 (n= 6), and in the Obese group (n= 6), BCS 7.5 to 9. Concentrate fasting blood samples were taken to determine triglycerides, total cholesterol, glucose, and insulin concentrations in plasma. Insulin sensitivity proxy (RISQI) and β-pancreatic secretion proxy (MIRG) were calculated from glucose and insulin data. The Obese group had higher triglyceride levels (P= 0.001), compared to other groups, and higher total cholesterol compared to the Ideal Group (P= 0.012). No differences in plasma glucose (P= 0.53), insulin (P= 0.10) concentrations and insulin sensitivity (RISQI: P= 0.463) were seen among groups. The Obese Group had a higher β-pancreatic secretion (MIRG: P= 0.048) compared to the Ideal Group. The increased BCS was related to the plasma fat metabolites a higher β-pancreatic secretion.
Keywords:
equine; triglycerides; cholesterolemia; insulin dysfunction; obesity